icometrix: Clinical Trials

6 trials sponsored by icometrix, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 active not recruiting, 1 enrolling by invitation, 1 recruiting. 2 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable2Active not recruiting 1, Enrolling by invitation 1

Follow icometrix: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Impact Through AI-assisted MS Care - A Prospective Multi-center Study
quantitative brain MRI (icobrain mr), Standard of Care (SOC) - Multiple Sclerosis, Radiologically Isolated Syndrome
Not applicableEnrolling by invitationicometrix7502025-10-092025-12-09
Study to Evaluate the Usability and Value of Integrated Digital Solutions in Medical Care of Participants With Multiple Sclerosis
MS Care Platform (icobrain ms and icompanion ms) - Relapsing Remitting Multiple Sclerosis
SuspendedHoffmann-La Roche5002024-10-212026-07-20
Remote MS Care in Antwerp
icompanion app - Multiple Sclerosis
Not applicableActive not recruitingUniversity Hospital, Antwerp1002024-05-232025-06-19
Clinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study.
Multiple Sclerosis, NMO Spectrum Disorder
Recruitingicometrix70002024-03-012025-12-12
CogMS - A Real-world Study Into Cognitive Impairment in People With Multiple Sclerosis
Custom study version of icompanion app - Multiple Sclerosis
Completedicometrix3002023-01-072023-12-07
CENTER-TBI: Collaborative European NeuroTrauma Effectiveness Research in TBI
Traumatic Brain Injury
CompletedUniversity Hospital, Antwerp45592014-12-192022-11-07

Conditions studied

Multiple Sclerosis (5)  ·  Brain Injuries, Traumatic (1)  ·  Disease Progression (1)  ·  Multiple Sclerosis, Relapsing-Remitting (1)  ·  Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (1)  ·  Nerve Degeneration (1)  ·  Neuromyelitis Optica (1)

Interventions

Standard of Care (1)

Countries

Germany (5)  ·  Belgium (3)  ·  Czechia (2)  ·  Italy (2)  ·  Spain (2)  ·  United States (2)  ·  Austria (1)  ·  Denmark (1)  ·  Finland (1)  ·  France (1)  ·  Hungary (1)  ·  Israel (1)  ·  Latvia (1)  ·  Lithuania (1)  ·  Netherlands (1)

Top investigators

Andrew Maas, MD, PhD (1)  ·  David Menon, MD, PhD (1)  ·  Friedemann Paul, PhD, MD (1)  ·  Guy Nagels, Prof. (1)

Results publications

PMID 25525693, PMID 31526754, PMID 31619435, PMID 32131882, PMID 32201256, PMID 32456684, PMID 32634435, PMID 32702336, PMID 32747075, PMID 33060506, PMID 33246186, PMID 33622371, PMID 33854024, PMID 34302517, PMID 34904191, PMID 35065038, PMID 35112104, PMID 35153967, PMID 35526554, PMID 35648213, PMID 35897070, PMID 36264365, PMID 36527074, PMID 37180469, PMID 37600483, PMID 37682406, PMID 38062304, PMID 38528477, PMID 38669706, PMID 38771081, PMID 38877571, PMID 39720422, PMID 41032948, PMID 42426883